We are live on ! Find out more
CO

Global Cord Blood Corporation

Delisted

CO was delisted on the 23rd of September, 2022.

35 hedge funds and large institutions have $96.3M invested in Global Cord Blood Corporation in 2019 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 9 increasing their positions, 12 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

3% less capital invested

Capital invested by funds: $99.1M → $96.3M (-$2.76M)

20% less funds holding

Funds holding: 4435 (-9)

25% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 12

82% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 11

Holders
35
Holders Change
-9
Holders Change %
-20.45%
% of All Funds
0.69%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
2
Increased
9
Reduced
12
Closed
11
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
JCM
1
Jayhawk Capital Management
Kansas
$59.9M -$3.71M -776,214 -6%
Renaissance Technologies
2
Renaissance Technologies
New York
$15.6M +$470K +98,332 +3%
RSCM
3
Rock Springs Capital Management
Maryland
$4.63M
Man Group
4
Man Group
United Kingdom
$4.54M
OMC
5
Oasis Management Company
Cayman Islands
$3.63M
Norges Bank
6
Norges Bank
Norway
$2.51M -$932K -195,181 -28%
QOP
7
Quinn Opportunity Partners
Virginia
$1.42M +$62K +12,984 +5%
Morgan Stanley
8
Morgan Stanley
New York
$728K -$169K -35,401 -20%
Millennium Management
9
Millennium Management
New York
$455K -$303K -63,440 -41%
Bank of America
10
Bank of America
North Carolina
$429K
PPA
11
Parametric Portfolio Associates
Washington
$409K -$24.1K -5,051 -6%
AC
12
Athos Capital
Hong Kong
$299K +$119K +24,850 +71%
PI
13
PEAK6 Investments
Illinois
$259K +$7.35K +1,540 +3%
Two Sigma Advisers
14
Two Sigma Advisers
New York
$236K -$30.6K -6,400 -12%
PP
15
Paloma Partners
Connecticut
$210K -$206K -43,166 -51%
Marshall Wace
16
Marshall Wace
United Kingdom
$196K +$17.2K +3,592 +10%
Northern Trust
17
Northern Trust
Illinois
$163K +$56.9K +11,918 +58%
Squarepoint
18
Squarepoint
New York
$154K +$147K +30,748 New
GCP
19
GSA Capital Partners
United Kingdom
$132K +$43.1K +9,030 +52%
BlackRock
20
BlackRock
New York
$121K +$81K +16,959 +232%
Citadel Advisors
21
Citadel Advisors
Florida
$102K -$142K -29,735 -59%
MFW
22
Mosaic Family Wealth
Missouri
$61K
Susquehanna International Group
23
Susquehanna International Group
Pennsylvania
$57K +$54.2K +11,353 New
FCI
24
Financial Counselors Inc
Kansas
$51K
Hudson Bay Capital Management
25
Hudson Bay Capital Management
Connecticut
$50K

CO Hedge Fund Activity: Q4 2019 in Review

35 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in Global Cord Blood Corporation (CO) for Q4 2019, worth a combined $96.3M — down 2.8% from $99.1M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of CO and 2 opened new positions — a net loss of 9 holders — while 12 trimmed existing stakes and 9 added.

The largest buyer was Renaissance Technologies, adding an estimated $470K. The largest seller was Jayhawk Capital Management, cutting an estimated $3.71M.

  • 35 institutional investors held Global Cord Blood Corporation (CO) as of Q4 2019, down from 44 in Q3 2019.
  • Funds reported $96.3M of Global Cord Blood Corporation stock for Q4 2019, down 2.8% quarter-over-quarter.
  • 2 funds opened new Global Cord Blood Corporation positions in Q4 2019 and 11 closed out, a net change of -9 holders.
  • The largest Global Cord Blood Corporation buyer in Q4 2019 was Renaissance Technologies, an estimated $470K added.
  • The largest Global Cord Blood Corporation seller in Q4 2019 was Jayhawk Capital Management, an estimated $3.71M sold.

Based on aggregated 13F filings for Q4 2019.